AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2019
Jun 3, 2019
31046_dirs_2019-06-03_b9c6dd31-4eeb-4ed9-989e-076febb11138.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-05-31
Reporting Person: Hill Emily Luisa (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-31 | Stock Option (Right To Buy) | $40.1 | A | 50000 | Acquired | 2029-05-30 | Common Stock (50000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7605 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right To Buy) | $43.69 | 2024-09-24 | Common Stock (7000.0) | 7000 | Direct |
| Stock Option (Right To Buy) | $51.0 | 2025-01-02 | Common Stock (1620.0) | 1620 | Direct |
| Stock Option (Right To Buy) | $30.86 | 2026-01-03 | Common Stock (2430.0) | 2430 | Direct |
| Stock Option (Right To Buy) | $11.23 | 2027-01-02 | Common Stock (3825.0) | 3825 | Direct |
| Stock Option (Right To Buy) | $18.01 | 2028-01-03 | Common Stock (14000.0) | 14000 | Direct |
| Stock Option (Right To Buy) | $33.02 | 2029-01-21 | Common Stock (21210.0) | 21210 | Direct |
Footnotes
F1: This option was granted on May 31, 2019 and vests over four years, with 25% of the shares underlying the option vesting on May 31, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning August 31, 2020.
F2: Currently exercisable.
F3: This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F4: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
F5: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
F6: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.